Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy

Cancer Genetics - Tập 237 - Trang 51-54 - 2019
Jess F. Peterson1, Rui R. He2, Hassan Nayer2, Raymund S. Cuevo3, James B. Smadbeck4, George Vasmatzis4, Patricia T. Greipp1, Rhett P. Ketterling1, Nicole L. Hoppman1, Linda B. Baughn1
1Division of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, United States
2Department of Pathology, Inova Fairfax Hospital, Falls Church, VA, United States
3Inova Schar Cancer Institute, Inova Fairfax Hospital, Falls Church, VA, United States
4Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN, United States

Tài liệu tham khảo

Arber, 2017, Acute myeloid leukaemia with recurrent genetic abnormalities, 130 Melnick, 1999, Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia, Blood, 93, 3167, 10.1182/blood.V93.10.3167.410k44_3167_3215 Adams, 2015, Acute promyelocytic leukemia: a review and discussion of variant translocations, Arch Pathol Lab Med, 139, 1308, 10.5858/arpa.2013-0345-RS Singh, 2019, Diagnosis of variant RARA translocation using standard dual-color dual-fusion PML/RARA FISH probes: an illustrative report, Hematol Oncol Stem Cell Ther, 12, 50, 10.1016/j.hemonc.2016.12.003 Drucker, 2014, BIMA V3: an aligner customized for mate pair library sequencing, Bioinformatics, 30, 1627, 10.1093/bioinformatics/btu078 Johnson, 2018, SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq), Cancer Genet, 221, 1, 10.1016/j.cancergen.2017.11.009 Aypar, 2019, Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia, Eur J Haematol, 102, 87, 10.1111/ejh.13179 Jovanovic, 2011, Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia, Front Oncol, 1, 35, 10.3389/fonc.2011.00035 Strehl, 2013, All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene, Leukemia, 27, 1606, 10.1038/leu.2012.371 Kluk, 2015, Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance by a custom next-generation sequencing assay, Cold Spring Harb Mol Case Stud, 1, 10.1101/mcs.a000307 Zhang, 2018, Clinical characteristics of acute promyelocytic leukemia with the STAT5B/RARA fusion gene, Blood Cells Mol Dis, 69, 71, 10.1016/j.bcmd.2017.09.007 Ciangola, 2019, STAT5b-RARa-positive acute myeloid leukemia: diagnostic and therapeutic challenges of a rare AML subtype, Leuk Res, 78, 21, 10.1016/j.leukres.2019.01.004 Wang, 2018, Successful treatment of a patient with acute promyelocytic leukemia with a STAT5B/RARA fusion gene using decitabine, Leuk lymphoma, 59, 763, 10.1080/10428194.2017.1357176 Chen, 2012, Acute promyelocytic leukemia with a STAT5B-RARα fusion transcript defined by arrary-CGH, FISH, and RT-PCR, Cancer Genet, 205, 327, 10.1016/j.cancergen.2012.02.007 Tomita, 2013, Mechanisms of action and resistance to all-trans- retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia, Int J Hematol, 717, 10.1007/s12185-013-1354-4